Get the Stockscreener App
30.91
2.09%
-0.66
After Hours:
30.91
Artivion Inc stock is traded at $30.91, with a volume of 344.28K.
It is down -2.09% in the last 24 hours and down -0.61% over the past month.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.
See More
Previous Close:
$31.57
Open:
$31.25
24h Volume:
344.28K
Relative Volume:
0.89
Market Cap:
$1.32B
Revenue:
$384.90M
Net Income/Loss:
$-851.00K
P/E Ratio:
-1,545.50
EPS:
-0.02
Net Cash Flow:
$12.83M
1W Performance:
-0.45%
1M Performance:
-0.61%
6M Performance:
-0.16%
1Y Performance:
+13.85%
1-Day Range:
$30.83
$31.64
1-Week Range:
$30.83
$32.16
52-Week Range:
$21.97
$32.94
Artivion Inc Stock (AORT) Company Profile
Name
Artivion Inc
Sector
Industry
Phone
(770) 419-3355
Address
1655 ROBERTS BOULEVARD N W, KENNESAW
Compare AORT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
30.91 | 1.48B | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
126.19 | 223.66B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
104.92 | 157.95B | 18.49B | 2.51B | 2.72B | 1.68 |
|
SYK
Stryker Corp
|
392.73 | 153.02B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
90.24 | 117.42B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
79.31 | 47.61B | 5.69B | 4.15B | 623.10M | 6.95 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-17-25 | Initiated | Canaccord Genuity | Buy |
| Oct-23-24 | Initiated | JMP Securities | Mkt Outperform |
| Sep-27-22 | Reiterated | Lake Street | Buy |
| Aug-08-22 | Initiated | Lake Street | Buy |
| Mar-03-22 | Initiated | Stifel | Buy |
Artivion Inc Stock (AORT) Latest News
What Fibonacci levels say about Artivion Inc. reboundPortfolio Review Summary with Five-Year Outlook - Newser
Is it time to cut losses on Artivion Inc.Pattern Recognition Tool for ROI Investors - Newser
How hedge fund analytics apply to Artivion Inc. stockFree Reversal Alert Based on RSI Indicator - Newser
How to interpret RSI for Artivion Inc. stockFree Reliable Investment Entry Point Signals - Newser
Artivion Inc. stock chart pattern explainedFree Weekly Setup With 3x Return Potential - Newser
What are the latest earnings results for Artivion Inc.Stock Strategy Target Finder From AI Tools - jammulinksnews.com
What momentum shifts mean for Artivion Inc.Momentum Trading Guide with Safety Limits - Newser
What makes Artivion Inc. stock price move sharplyFree Early Entry Tips With Low Risk Zone - Newser
Will Artivion Inc. stock benefit from interest rate changesBuy and Exit Strategy Based on Momentum - Newser
Is Artivion Inc. forming a bottoming basePrice Spike Prediction for Active Traders - Newser
How Artivion Inc. stock performs during market volatilityFree Target Return Focused Trade Insights - Newser
Artivion to Participate in Upcoming Investor Conferences | AORT Stock News - GuruFocus
Artivion Announces Double Conference Schedule: Canaccord Growth and Needham MedTech Investor Events - Stock Titan
Custom Dashboard Highlights Artivion Inc. Price MomentumChart-Based Trade Entries Gain Analyst Support - metal.it
Can Artivion Inc. Escape Recent Bear ChannelAI Based High Gain Watchlist Scanner Shared - metal.it
Victory Capital Management Inc. Decreases Stock Position in Artivion, Inc. (NYSE:AORT) - Defense World
What are analysts’ price targets for Artivion Inc. in the next 12 monthsUnlock your trading potential today - jammulinksnews.com
Citizens JMP reiterates Market Outperform rating on Artivion stock - Investing.com Australia
Citizens JMP reiterates Market Outperform rating on Artivion stock By Investing.com - Investing.com Canada
What are the technical indicators suggesting about Artivion Inc.Build a portfolio that outperforms the market - jammulinksnews.com
Is Artivion Inc. Stock Overbought or Oversold RSI Indicator AnalysisSecure Your Capital Strategy - metal.it
How strong is Artivion Inc. company’s balance sheetTriple returns potential - jammulinksnews.com
BlackRock, Inc. Reduces Stake in Artivion Inc: A Detailed Analysis - GuruFocus
What drives Artivion Inc. stock priceHigh-impact investment strategies - PrintWeekIndia
What analysts say about Artivion Inc. stockFree Investment Timing Strategies - Autocar Professional
Leading Cardiac Surgery Company Artivion Sets Q2 2025 Earnings Release Date - Stock Titan
New York State Common Retirement Fund Increases Position in Artivion, Inc. (NYSE:AORT) - Defense World
Bank of New York Mellon Corp Sells 7,885 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion, Inc. (NYSE:AORT) Receives $32.40 Consensus Target Price from Brokerages - Defense World
Artivion Inc. Stock Analysis and ForecastExtraordinary market timing - Autocar Professional
3 Healthcare Stocks with Warning Signs - FinancialContent
Is Artivion Inc. a good long term investmentExceptional market positioning - jammulinksnews.com
Artivion Inc Stock (AORT) Financials Data
Revenue
Net Income
Cash Flow
EPS
3.31%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):